Clinical Trial Update: Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of Subjects [Phase 1]

View source ↗

Summary

This Phase 1 trial assesses the concentrations of Besifloxacin, Moxifloxacin, and Gatifloxacin in the aqueous humor of subjects undergoing cataract extraction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• BESIVANCE (besifloxacin)
• VIGAMOX (Moxifloxacin hydrochloride)
• Zymar (gatifloxacin)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Cataract Extraction | Phase 1 | Status: COMPLETED | Results posted: 2010-10-29